What is the main purpose of this 8-K filing from Gilead Sciences?

The main purpose of this 8-K filing is to officially announce and provide access to Gilead Sciences' financial results for the quarter ended March 31, 2023. It includes a press release with the detailed financial performance.

Where can I find the specific financial numbers for Gilead's Q1 2023 results?

The specific financial numbers, including GAAP and non-GAAP figures, are detailed in the press release filed as Exhibit 99.1 to this 8-K report. Investors should refer to that document for the comprehensive data.

What is the difference between GAAP and non-GAAP information presented by Gilead?

GAAP (Generally Accepted Accounting Principles) refers to the standard set of accounting principles used in the U.S. Non-GAAP measures are alternative metrics that exclude certain items or use different accounting treatments. Gilead believes its non-GAAP measures provide useful insights for investors, but they may be calculated differently by other companies and should be considered alongside GAAP results.

What is a reconciliation between GAAP and non-GAAP measures?

A reconciliation is a statement that shows how the non-GAAP financial measures are derived from the most directly comparable GAAP measures. It typically involves adding back or removing specific items to arrive at the non-GAAP figure. Gilead provides these reconciliations in its Q1 2023 earnings press release.

GILD 8-K: Earnings & Results

Summary

Gilead Sciences, Inc. (GILD) filed an 8-K on April 27, 2023, to report its financial results for the quarter ended March 31, 2023. The filing primarily consists of a press release detailing these results. Investors should note that Gilead presents both GAAP and non-GAAP financial information, and the company believes the non-GAAP measures offer useful insights for understanding operational performance. The press release, filed as Exhibit 99.1, contains the detailed financial tables and reconciliations between GAAP and non-GAAP figures. While this 8-K itself does not contain the specific financial numbers, it serves as the official notification and filing vehicle for the quarterly earnings announcement. Investors are directed to the attached press release for the comprehensive breakdown of Gilead's financial condition and results of operations for the first quarter of 2023.

Key Highlights

1Gilead Sciences (GILD) announced its Q1 2023 financial results via an 8-K filing on April 27, 2023.
2The primary content of the filing is a press release (Exhibit 99.1) detailing the company's performance for the quarter ended March 31, 2023.
3Gilead provides both GAAP and non-GAAP financial information to investors.
4The company states that non-GAAP financial measures are used internally for operational and financial planning and are considered useful for investors.
5A reconciliation between GAAP and non-GAAP financial information is available within the press release.
6This 8-K filing serves as the official notification of the quarterly earnings release.
7Information in this filing is not deemed 'filed' for Section 18 of the Exchange Act or incorporated by reference in other filings.

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Apr 27, 2023)

Summary

Key Highlights

Frequently Asked Questions